Physician
Midlands Neurology & Pain Assoc, P.A
Midlands Neurology & Pain Assoc, P.A was paid $2.55M by Medicaid between Jan 2018 and Dec 2024, across 42 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 55% of everything it billed.
33Billing provider infoMIDLANDS NEUROLOGY & PAIN ASSOC, P.A
COLUMBIA, SC 29205
COLUMBIA, SC 29205
33aNPI1629084132assigned 08/01/2006
33bProvider typeNeurology Physician
28Total paid$2.55M
24GClaims66,584
24DCodes billed42
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Neurology Physician providers in South Carolina
Rank by total paid#2 of 37
Median peer was paid$41K
This provider vs. median62×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,023 | $196K | |
| 2019 | 8,714 | $287K | |
| 2020 | 9,314 | $370K | |
| 2021 | 11,646 | $486K | |
| 2022 | 12,304 | $477K | |
| 2023 | 10,383 | $449K | |
| 2024incomplete | 8,200 | $284K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 55% | 24,795 | 21,793 | $1.40M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 21% | 17,097 | 15,530 | $527K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 15% | 16,186 | 13,348 | $381K |
| L0650 | Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf | 3.1% | 181 | 128 | $80K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.5% | 1,546 | 1,439 | $64K |
| 99205 | Prolong outpt/office vis | 1.7% | 429 | 369 | $43K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,205 | 766 | $9K |
| 92546 | <1% | 190 | 116 | $7K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 87 | 82 | $7K |
| 92540 | <1% | 160 | 145 | $6K | |
| 20610 | <1% | 258 | 186 | $5K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 503 | 249 | $5K |
30 more codes
| 95923 | <1% | 102 | $3K | |
| 93922 | <1% | 105 | $3K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 427 | $3K |
| 95921 | <1% | 89 | $2K | |
| 96130 | <1% | 63 | $1K | |
| 99408 | <1% | 24 | $567.41 | |
| 92547 | <1% | 159 | $416.76 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 44 | $403.76 |
| 93000 | <1% | 34 | $286.69 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 45 | $251.29 |
| 86803 | <1% | 14 | $186.74 | |
| 86703 | <1% | 17 | $164.40 | |
| A4550 | Surgical trays | <1% | 84 | $127.22 |
| 36415 | Collection of venous blood by venipuncture | <1% | 76 | $110.31 |
| L0120 | Cervical, flexible, non-adjustable, prefabricated, off-the-shelf (foam collar) | <1% | 12 | $83.55 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 18 | $73.62 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 271 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 102 | $0.00 |
| 97016 | 0% | 390 | $0.00 | |
| 1036F | 0% | 92 | $0.00 | |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 0% | 18 | $0.00 |
| E0730 | Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation | 0% | 14 | $0.00 |
| G3002 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.) | 0% | 849 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 159 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 94 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 99 | $0.00 |
| 4004F | 0% | 132 | $0.00 | |
| 99490 | Ccm add 20min | 0% | 103 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 91 | $0.00 |
| 3046F | 0% | 220 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOGBURU-OGBONNAYA MD, E (PRESIDENT CEO)